BioSpace News Archive

Business

Myovant Provides Corporate Update and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2018

Myovant Sciences announced corporate updates and reported financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2018.

June 7, 2018
·
15 min read
Business

Stallergenes Greer Provides Business Update and Refines Its 2018 Financial Outlook

Company now expects 2018 net sales to be in the range of €270 million to €280 million and EBITDA to be in the range of €40 million to €50 million.

June 7, 2018
·
6 min read
Business

4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Patients With Solid Tumours

4D pharma plc is a clinical stage biopharmaceutical company, pioneering the development of Live Biotherapeutic Products

June 7, 2018
·
2 min read
Business

CENTOGENE Partners with the Universities of Greifswald and Rostock to Develop Fast-Tracked Diagnostic Workflow for Personalized Immune-based Therapies for Colon and Pancreatic Tumors

CENTOGENE is committed to developing a fast-track diagnostic workflow which lays the groundwork for individualized vaccination therapy in cancer.

June 7, 2018
·
3 min read
Vertex Data Presented at European Cystic Fibrosis Society (ECFS) Conference Demonstrate Early and Long-Term Disease-Modifying Potential of Treating the Underlying Cause of CF

Data from KALYDECO® (ivacaftor) studies show the potential to modify the long-term progression of the disease

June 7, 2018
·
21 min read
Business

Luye expanding I-O deal with U.S. firm Elpis to focus on CAR T therapies

License agreement to jointly develop chimeric antigen receptor T-cell therapies and biologic drug candidates in immuno-oncology

June 7, 2018
·
4 min read
Business

Egalet Appoints Industry Veteran John Varian to Board of Directors

Varian most recently served as the CEO and director of XOMA, an antibody business, where he led the refocusing and refinancing of the company

June 7, 2018
·
5 min read
Business

Kenneth Martino Joins MedRisk as Executive Vice President of Business Development

Responsibilities include identifying and evaluating business development opportunities both domestically and internationally, including analyzing competitive and market trends, developing and managing strategic partnerships, acquisition identification and integration and organic growth strategies.

June 7, 2018
·
2 min read
Policy

OmniLytics, Inc. and Certis USA Join Forces to Develop and Market New Bacterial Disease Control Products in Agriculture

OmniLytics has entered into an exclusive U.S. sales and marketing collaboration with Certis USA, LLC for its AgriPhage line of biopesticides.

June 7, 2018
·
3 min read
Mictoryl® Pediatric (propiverine hydrochloride) now covered by several public drug plans to treat symptoms associated with overactive bladder

Indicated for the symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in pediatric patients, from the age of 5 years, with overactive bladder.

June 7, 2018
·
1 min read